CURRENT SERIES:
Advances in the Treatment of Hyperhidrosis
June 29, 2018
June 29, 2018
July 23, 2018
July 23, 2018
August 03, 2018
August 10, 2018
August 17, 2018
NOW PLAYING
Treating Hyperhidrosis: Glycopyrronium Tosylate
8 of 13
August 17, 2018
August 23, 2018
August 30, 2018
August 30, 2018
September 06, 2018

Treating Hyperhidrosis: Glycopyrronium Tosylate

Shawn Davis, PharmD, highlights the potential for treating primary axillary hyperhidrosis with glycopyrronium tosylate, an emerging treatment option.


Shawn Davis, PharmD: Glycopyrronium tosylate is an exciting therapy that will enable patients to have something topical. This is something that I believe is going to help patients. It is really going to have an impact on their lives and change the way that they live their lives.

Glycopyrronium tosylate is a medication that is actually going to meet the needs of patients in a way that they don’t have today. There aren’t good therapies on the market for patients to treat their hyperhidrosis and the condition that they have.

The next part is going to really be seeing what managed care’s outlook will be in paying for these medications. We are going to have a therapy. Just like with all therapies that are on the market, how do we pay for it? What’s going to be the mechanism by which payers and patients split the cost?

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!